Abstract
Currently, the world is witnessing an aging population and an increase in the number of diseases characteristic of the elderly. These include cardiovascular disease (CVD), atherosclerosis, osteoporosis, type 2 diabetes mellitus (DM) (non-insulin-dependent diabetes mellitus - NIDDM). Increasing life expectancy requires improving the quality of life of patients. Given the angioprotective effect of hormone replacement therapy (HRT), there is an increasing interest in its use in postmenopausal women for the prevention and treatment of menopausal disorders, atherosclerosis, and osteoporosis. Among the huge contingent of patients with hyperglycemia, almost 80% are patients with NIDDM, of which 65-70% are women. This fact provides a great scientific and practical interest in the features of metabolic disorders (hyperglycemia, hyperlipidemia) in postmenopausal women.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
